These drugs may help slow or reverse immune system decline.
Academic rigour, journalistic flair
Articles on Vaccines
Displaying 461 - 480 of 785 articles
Vaccines work by teaching your immune system about new viruses. Your immune cells are very clever – they will remember what they learnt, and protect you if you encounter that virus in the future.
There are many scientific and ethical challenges ahead. But these types of trials have helped in the development of vaccines against a few diseases. Could they do the same for COVID-19?
With lives depending on a vaccine, trust in Canada’s COVID-19 Vaccine Task Force is crucial. Members of the task force need to make any industry links or potential conflicts of interest publicly clear.
Our first exposure to a pathogen, either naturally or via vaccination, can affect how our immune system responds in the future to the same or similar pathogens.
Both Moderna and AstraZeneca have used cutting-edge designs to reduce their vaccines’ development time.
A group of 28 vaccine researchers said we might have a vaccine by late-2021, though it could take until well into 2022.
From 2017 to 2019, Twitter users in the United States saw many tweets related to vaccination but only rarely encountered anti-vaccine content and almost never saw content from bots.
The history of anti-vaccination theories can help us understand how such claims capture a popular following. The same misinformation used against 19th century smallpox vaccine is still in use today.
Australians who refuse vaccines spend a lot of time trying to understand vaccine choices and think they’re making evidence-based decisions.
The way we deliver vaccines continues to evolve. Here’s a look at needle-free vaccine technologies from history to the modern day.
Medical innovation is often accelerated in a time of crisis.
A pediatrician answers parents’ questions about catching up on missed childhood vaccinations and why that’s so important.
An unprecedented level of research has gone into understanding the novel coronavirus. Here’s what we still don’t know.
Australia’s contribution to the global COVAX initiative helps secure future vaccines. Here’s the full field of candidates.
Public trust is key to a successful immunisation programme.
A sports management scholar weighs in on the potential consequences of holding Big Ten football games in the fall instead of waiting for a vaccine or better safety procedures.
Several vaccines are in Phase 3 trials. So when will we know whether any of these will protect against COVID-19?
There’s a targeted subunit protein vaccine, an mRNA vaccine, and a needle-free DNA vaccine. Here’s what that all means.
Researchers rarely report what’s in a placebo.
Top contributors
-
Professorial Fellow, University of Canberra
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
-
Professor of Medicine, University of Virginia
-
Research associate, Warren Alpert Medical School, Brown University, Brown University
-
Professor of Microbiology, School of Medicine, University of Washington
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Lecturer in Virology, Queen's University Belfast
-
Associate Professor of Biology, Rochester Institute of Technology
-
Professor of Immunology, Vice-Chancellors Distinguished Professorial Fellow, Head of Immunology and Translational Research, Victoria University
-
Assistant Professor of Political Science, Oklahoma State University
-
Associate Professor and ARC Future Fellow, The University of Western Australia
-
Senior Lecturer; MD, Victoria University
-
Associate Professor, Discipline of Childhood and Adolescent Health, University of Sydney
-
Professor of Immunology, RMIT University
-
Professor, Discipline of Paediatrics and Child Health, University of Sydney
